| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/30/2013 | WO2013078393A1 Treating bladder cancer patients and identifying bladder cancer patients responsive to treatment |
| 05/30/2013 | WO2013078378A1 Methods of treatment using an antibody against interferon gamma |
| 05/30/2013 | WO2013078362A1 Compositions and methods for monitoring transmembrane trafficking |
| 05/30/2013 | WO2013078332A1 Analyte detection using magnetic hall effect |
| 05/30/2013 | WO2013078253A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 05/30/2013 | WO2013078244A1 Carboxy x rhodamine analogs |
| 05/30/2013 | WO2013078227A1 Signal amplification in lateral flow and related immunoassays |
| 05/30/2013 | WO2013078216A1 Glucose-6-phosphate dehydrogenase assays |
| 05/30/2013 | WO2013078145A1 Biomarkers for cancers responsive to modulators of hec1 activity |
| 05/30/2013 | WO2013078122A1 Diabetes diagnosis through the detection of glycated proteins in urine |
| 05/30/2013 | WO2013078118A1 Methods for determining the susceptibility of a virus to an attachment inhibitor |
| 05/30/2013 | WO2013078107A1 Fibrinogen assay |
| 05/30/2013 | WO2013077982A1 High throughput selection of specific cell binding and lytic polypeptides |
| 05/30/2013 | WO2013077907A1 Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non- response alleles |
| 05/30/2013 | WO2013077886A2 Protease degradable polypeptides and uses thereof |
| 05/30/2013 | WO2013077864A1 Method for self-referenced confidence test |
| 05/30/2013 | WO2013077803A1 Testing system and method for testing |
| 05/30/2013 | WO2013077802A1 Testing system arrangement and method for testing |
| 05/30/2013 | WO2013077751A1 Method for evaluating the sensitivity and specificity of fast malaria-diagnosis test kits |
| 05/30/2013 | WO2013077693A1 Beef-specific age determination spr kit and beef-specific age determination method using same |
| 05/30/2013 | WO2013077576A1 Microfluidic semiconductor sensor |
| 05/30/2013 | WO2013077496A1 Method and device for treating ship ballast water |
| 05/30/2013 | WO2013077458A1 Anti-human trop-2 antibody exhibiting antitumor activity in vivo |
| 05/30/2013 | WO2013077425A1 Methods for producing retinal tissue and retina-related cell |
| 05/30/2013 | WO2013077332A1 Method for detecting matrix metalloproteinase-3 by latex agglutination method |
| 05/30/2013 | WO2013077027A1 Polymer material simulation method |
| 05/30/2013 | WO2013076959A1 Measuring method for biological substance and measuring device therefor |
| 05/30/2013 | WO2013076943A1 Single molecule detection method and single molecule detection apparatus for biological molecule, and disease marker testing apparatus |
| 05/30/2013 | WO2013076618A1 Device for measuring the concentration of a gas dissolved in an electrical insulation oil. |
| 05/30/2013 | WO2013076505A1 Detector apparatus and method |
| 05/30/2013 | WO2013076501A2 Screening method |
| 05/30/2013 | WO2013076444A1 Methods for detecting of benign conditions |
| 05/30/2013 | WO2013076402A1 Method for detecting the presence of bubbles during operations of injecting resin for the manufacture of fibre composite components |
| 05/30/2013 | WO2013076312A1 Method and device for determining the glass transition temperature of a product |
| 05/30/2013 | WO2013076304A1 Monoclonal antibody for the detection of snap/clip tag |
| 05/30/2013 | WO2013076295A1 Methods for screening a brca1 loss-of-function in a subject suffering from a cancer |
| 05/30/2013 | WO2013076240A1 Novel markers of papillary and reticular fibroblasts and uses thereof |
| 05/30/2013 | WO2013076222A1 Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer |
| 05/30/2013 | WO2013076181A1 Methods of enrichment and isolation of regulatory t-cells and use of the same |
| 05/30/2013 | WO2013076157A1 Marker for blood coagulation |
| 05/30/2013 | WO2013076143A1 Detecting analytes |
| 05/30/2013 | WO2013076134A1 Symmetrical test element for detecting an analyte |
| 05/30/2013 | WO2013076089A2 Liquid medium and sample vial to be used in a method for detecting cancerous cells in a cell sample |
| 05/30/2013 | WO2013076082A1 Sample vial for digital holographic analysis of a liquid cell sample |
| 05/30/2013 | WO2013076076A1 Pool surveillance system and associated surveillance method |
| 05/30/2013 | WO2013075979A1 Method for sensor calibration |
| 05/30/2013 | WO2013075857A1 Method for determining biochemical parameters of a body fluid |
| 05/30/2013 | WO2013075608A1 Chimeric recombinant antigen and use thereof |
| 05/30/2013 | WO2013075584A1 Method for real-time on-line monitoring of concrete freeze-thaw damage |
| 05/30/2013 | WO2013075403A1 System and process for determining and analysing surface property parameters of substance based on kinetic method |
| 05/30/2013 | WO2013075237A1 Mutations of histone proteins associated with proliferative disorders |
| 05/30/2013 | WO2013075233A1 Method for treating brain cancer |
| 05/30/2013 | WO2013075167A1 Binding agent |
| 05/30/2013 | WO2013052926A3 Methods and compositions for single chain variable region enox2 antibodies for cancer detection and diagnosis |
| 05/30/2013 | WO2013052498A3 Caspase 9 inhibition and bri2 peptides for treating dementia |
| 05/30/2013 | WO2013051846A3 Complex membrane for a western blot including pvdf nanofibers, and method for manufacturing same |
| 05/30/2013 | WO2013049398A3 Protein-protein interaction as biomarkers |
| 05/30/2013 | WO2013046159A4 Apparatus and method for fluid phase fraction determination using x-rays |
| 05/30/2013 | WO2013043126A8 Method(s) for obtaining a foetal red blood cell |
| 05/30/2013 | WO2013041879A3 Wound prognosis |
| 05/30/2013 | WO2013022322A3 Composition for mass analysis of haptoglobin and method for diagnosing cancer using same |
| 05/30/2013 | WO2013022284A3 Microchip-based apparatus for examining platelet composite functions |
| 05/30/2013 | WO2013022262A3 Human resistin receptor, and use thereof |
| 05/30/2013 | WO2013019108A3 Method for the detection of egg yolk |
| 05/30/2013 | WO2013017959A3 Flow-valve diagnostic microfluidic system |
| 05/30/2013 | WO2013009143A3 Marker for diagnosing diabetic retinopathy |
| 05/30/2013 | WO2013008163A8 Process for the quantitative determination of total chlorine in a matrix |
| 05/30/2013 | WO2012143556A3 Analyzing the expression of biomarkers in cells with moments |
| 05/30/2013 | WO2012078053A8 Novel marker for detection of bladder cancer and/or inflammatory conditions of the bladder |
| 05/30/2013 | US20130137856 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof |
| 05/30/2013 | US20130137753 Methods and compositions for the diagnosis and treatment of breast cancer |
| 05/30/2013 | US20130137748 Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis |
| 05/30/2013 | US20130137632 Method of Treating a Subject According to Biomarkers for Insulin Resistance |
| 05/30/2013 | US20130137627 Methods and kits for identifying a premature infant at risk of having or developing bronchopulmonary dysplasia |
| 05/30/2013 | US20130137607 Point of care immunization testing system |
| 05/30/2013 | US20130137603 Newly identified colon cancer marker and diagnostic kit using the same |
| 05/30/2013 | US20130137598 Method of detecting surrogate markers in a serum sample |
| 05/30/2013 | US20130137595 Biomarkers for lymphoma |
| 05/30/2013 | US20130137592 Biomarkers |
| 05/30/2013 | US20130137589 Analysis of y-chromosome str markers |
| 05/30/2013 | US20130137192 Immunochromatography reagent composition, and measurement method using same |
| 05/30/2013 | US20130137191 Method and kit for detecting the early onset of renal tubular cell injury |
| 05/30/2013 | US20130137190 Immunochromatographic device |
| 05/30/2013 | US20130137189 Method and apparatus for performing a lateral flow assay |
| 05/30/2013 | US20130137188 Method of detecting rupture of membranes |
| 05/30/2013 | US20130137187 Synthetic active peptide fragments |
| 05/30/2013 | US20130137185 Mass spectrometry of steroidal compounds in multiplexed patient samples |
| 05/30/2013 | US20130137182 Blood pre-treatment apparatus and pre-treatment method using the same |
| 05/30/2013 | US20130137124 Diagnostic test to exclude significant renal injury |
| 05/30/2013 | US20130137123 Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof |
| 05/30/2013 | US20130137122 Diagnosis and monitoring of chronic renal disease using ngal |
| 05/30/2013 | US20130137121 Method And Device For Assay Determination |
| 05/30/2013 | US20130137118 Integrin heterodimer and a subunit thereof |
| 05/30/2013 | US20130137117 Method for preparing protein imprinted polymers and use thereof |
| 05/30/2013 | US20130137116 Method and kit for detecting the early onset of renal tubular cell injury |
| 05/30/2013 | US20130137115 Homogeneous detection method |
| 05/30/2013 | US20130137114 Bioprobe, Method of Preparing the Bioprobe, and Analysis Apparatus and Method Using the Bioprobe |
| 05/30/2013 | US20130137113 Photoreactive Regulator of Protein Function and Methods of Use Thereof |
| 05/30/2013 | US20130137106 Tumor Marker and Methods of Use Thereof |
| 05/30/2013 | US20130137102 Methods and kits for modulating tumor invasiveness and metastatic potential |